Appearance | White to Almost white powder to crystal |
Purity(HPLC) | 99.40% |
Purity(Volumetric Analysis) | min. 98.0 % |
Melting point | 129.0 to 133.0 °C |
Dabigatran Etexilate
Ethyl N-[[2-[[4-[N-[(Hexyloxy)carbonyl]carbamimidoyl]anilino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-2-pyridinyl-β-alaninate, Ethyl 3-[2-[[[4-[N-[(Hexyloxy)carbonyl]carbamimidoyl]phenyl]amino]methyl]-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido]propanoate
Purity / Analysis Method | >98.0%(T)(HPLC) |
Molecular Formula / Molecular Weight | C34H41N7O5 = 627.73 |
Physical State (20 deg.C) | Solid |
Storage Temperature | 0-10°C |
CAS RN | 211915-06-9 |
Unit | Price |
10 g | 3500 |
25 g | 5000 |
100 g | 12500 |
Note | • Pharmaceutical Ingredients (for Research and Experimental Use) is provided as delivered and specified by the issuing Pharmacopoeia. |
---|